Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in the Volpara Density clinical application for breast density assessment. The updated version of VolparaDensity more accurately reflects breast density from images captured using the Hologic SmartCurve system.

The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation Oncology • Biology • Physics (Red Journal).

Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that delivers workflow improvements, new imaging capabilities and artificial intelligence-assisted functionality for hands-free operation during interventional procedures. Designed with the musculoskeletal (MSK) practitioner in mind, the HS1 System features advanced functionality to support confident diagnoses and treatment management at the point of care.

January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve radiation therapy treatment planning. With its integrated portfolio of computed tomography (CT) and magnetic resonance imaging (MRI) systems and intelligent treatment planning software, Philips supports clinicians in making confident therapy decisions.

January 30, 2019 – The Radiological Society of North America (RSNA) published the first issue of its new online journal Radiology: Artificial Intelligence on Jan. 30, 2019. This new journal highlights the emerging applications of machine learning and artificial intelligence in the field of imaging across multiple disciplines.

January 30, 2019 — Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in people who undergo weight loss treatments for obesity, according to a new study published in the journal Radiology.1

January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ultrasound technology known as the QTscan. The U.S. Food and Drug Administration (FDA)-cleared 3-D ultrasound breast imaging technology provides women an option with no radiation, no compression and no injections.

ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the correlation of imaging signals observed using ImaginAb’s CD8+ T cell ImmunoPET imaging agent, standard-of-care scans and immunohistochemistry analysis of CD8 in biopsied tissues.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now